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a  b  s  t  r  a  c  t
Pyomyositis is a pyogenic infection of skeletal muscle that arises from hematogenous spread
and  usually presents with localized abscess. This muscle infection has been rarely reported
in  adult-onset systemic lupus erythematous and, to the best of our knowledge, has not been
diagnosed in pediatric lupus population. Among our childhood-onset systemic lupus ery-
thematous population, including 289 patients, one presented pyomyositis. This patient was
diagnosed with childhood-onset systemic lupus erythematous at the age of 10 years-old.
After six years, while being treated with prednisone, azathioprine and hydroxychloroquine,
she was hospitalized due to a 30-day history of insidious pain in the left thigh and no appar-
ent  trauma or fever were reported. Her physical examination showed muscle tenderness
and woody induration. Laboratory tests revealed anemia, increased acute phase reactants
and  normal muscle enzymes. Computer tomography of the left thigh showed collection
on  the middle third of the vastus intermedius,  suggesting purulent stage of pyomyositis.
Treatment with broad-spectrum antibiotic was initiated, leading to a complete clinical
resolution. In conclusion, we described the ﬁrst case of pyomyositis during childhood in
pediatric lupus population. This report reinforces that the presence of localized muscle
pain in immunocompromised patients, even without elevation of muscle enzymes, should
raise the suspicion of pyomyositis. A prompt antibiotic therapy is strongly recommended.
©  2013 Elsevier Editora Ltda. All rights reserved.
Piomiosite  no  lúpus  eritematoso  sistêmico  juvenil
r  e  s  u  m  oalavras-chave:
iomiosite
úpus eritematoso sistêmico juvenil
nfecc¸ão
A piomiosite é uma infecc¸ão piogênica da musculatura esquelética, decorrente da
disseminac¸ão hematogênica e geralmente acompanhada de formac¸ão de abscesso local-
izado.  Esta infecc¸ão da musculatura é raramente descrita em adultos com lúpus eritematoso
sistêmico (LES) e, até onde se sabe, ainda não o foi em pacientes com LES juvenil (LESJ).
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De nossos 289 pacientes com LESJ, uma apresentou piomiosite. Diagnosticada com LESJ
aos  10 anos de idade e após seis anos de tratamento com prednisona, azatioprina e hidroxi-
cloroquina, a paciente foi hospitalizada em razão de um histórico de 30 dias de dor insidiosa
na  coxa esquerda, sem relato algum de trauma aparente ou febre. O exame físico mostrou
músculos sensíveis e com endurecimento lenhoso. Os exames laboratoriais revelaram ane-
mia, aumento de reagentes de fase aguda e enzimas musculares normais. A tomograﬁa
computadorizada da coxa esquerda mostrou colec¸ão no terc¸o médio do vasto intermédio,
sugerindo estágio purulento de piomiosite. Iniciou-se tratamento com antibiótico de largo
espectro, que levou à resoluc¸ão clínica completa. Em suma, descreveu-se o primeiro caso
de  piomiosite em pacientes com LESJ encontrado neste servic¸o. Este relato reforc¸a que a
presenc¸a  de dor muscular localizada em pacientes imunocomprometidos, ainda que sem
aumento de enzimas musculares, deve sugerir o diagnóstico de piomiosite. Recomenda-se
tratamento imediato com antibióticos.
© 2013 Elsevier Editora Ltda. Todos os direitos reservados.Introduction
Pyomyositis is a pyogenic infection of skeletal muscle that
arises from hematogenous spread and usually presents
with localized abscess.1 Infectious myopathy is associated
with immunocompromised conditions, especially human
immunodeﬁciency virus (HIV) infection, diabetes melli-
tus, malignancy, immunosuppressive drugs and rheumatic
diseases.1–7
Of note, infections are one of the main causes of morbid-
ity and mortality in adult systemic lupus erythematosus (SLE)
and childhood-onset SLE (C-SLE) patients,8,9 and may involve
the skeletal muscle. Pyomyositis has been rarely reported in
adult SLE,3–7 and to the best of our knowledge, it has not been
diagnosed during childhood in pediatric lupus population.
We reviewed our data from January 1983 to July 2013 and
included 5593 patients of Pediatric Rheumatology Unit of Insti-
tuto da Crianc¸a da Faculdade de Medicina da Universidade de
São Paulo. We  identiﬁed 289 (5.1%) C-SLE patients that fulﬁlled
the American College of Rheumatology (ACR) classiﬁcation
criteria.10 One (0.34%) of them had a pyomyositis episode after
C-SLE diagnosis was established and was described herein.
Case  report
A 10-year-old girl was diagnosed with C-SLE based on discoid
skin rash, pericarditis, psychosis, lymphopenia, thrombo-
cytopenia, proteinuria, antinuclear antibodies (ANA) 1/1280
(nuclear homogenous pattern), and presence of anti-double-
stranded DNA (anti-dsDNA) antibody, fulﬁlling the ACR
classiﬁcation criteria for SLE.11 At that moment, the SLE
Disease Activity Index 2000 (SLEDAI-2K) score11 was 28
based on the following ﬁndings: psychosis, proteinuria, cel-
lular casts, alopecia, pleuritis, pericarditis, low levels of
C3 and C4, presence of anti-dsDNA, fever and thrombocy-
topenia. She was treated with prednisone (2.0 mg/kg/day)
that was progressively tapered to 2.5 mg/day, hydroxychloro-
quine (5.0 mg/kg/day) and azathioprine (2.0 mg/kg/day). At
the age of 16 years, she was hospitalized in our service
with a 30-day history of insidious pain in the middleof left thigh, without cramps, apparent trauma or fever.
Her physical examination showed localized muscle ten-
derness and woody induration. She did not present skin
erythema and local heat. At that time, she was on pred-
nisone (0.95 mg/kg/day), azathioprine (2.25 mg/kg/day) and
hydroxychloroquine (5.0 mg/kg/day) due to severe alopecia,
discoid skin rash, photosensitivity and oral ulcers. Labo-
ratory tests revealed hemoglobin 9.3 mg/L, hematocrit 29%,
white blood cell count 8700 mm3 (71% neutrophils, 20% lym-
phocytes and 8% monocytes), platelet count 202,000 mm3,
C-reactive protein 46.9 mg/L (reference value <5 mg/L), eryth-
rocyte sedimentation rate 54 mm/1st hour (normal range
0–20 mm/h), proteinuria 0.12 g/24 h, urea 41 mg/dL (normal
range 15–45 mg/dL) and creatinine 0.36 mg/dL (normal range
0.6–0.9 mg/dL), C3 75 mg/dL (normal range 90–180 mg/dL) and
C4 9.9 mg/dL (normal range 10–40 mg/dL). Muscle enzymes
tests performed showed: aspartate aminotransferase 31 U/L
(normal range 10–34 U/L), alanine aminotransferase 34 U/L
(normal range 10–44 U/L), creatine kinase 64 U/L (normal range
24–204 U/L). Anti-dsDNA was positive, and SLEDAI-2K was 4.
Computed tomography (CT) of the left thigh showed collec-
tion on the middle third of the vastus intermedius muscle,
dimensions 5.0 cm × 3.0 cm × 2.0 cm,  strongly suggestive of
purulent stage of pyomyositis. The patient was submitted to
an ultrasound-guided puncture, but no ﬂuid was obtained.
Blood culture did not identify any organisms. Treatment with
intravenous antibiotics, such as cefepime (150 mg/kg/day) and
clindamycin (40 mg/kg/day), was administered for a seven-
day period. She was then discharged with oral clindamycin
(40 mg/kg/day) for more  seven days, resulting in a complete
clinical resolution.
Discussion
Pyomyositis had never been reported in C-SLE population fol-
lowed in our tertiary University Hospital in the last 30 years.
The presence of localized muscle pain with indurations in an
immunosuppressed patient suggested this diagnosis.
This infectious myopathy was ﬁrst described in 1885 by
Scribba12 and is a rare pyogenic infection of muscle tissue. In
childhood, the most affected regions are thighs and hips.2,13
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t is usually caused by Staphylococcus aureus,  Streptococcus sp.
nd Escherichia coli.2,7 However, in more  than two thirds of the
ases, the etiological agent is not identiﬁed in blood cultures,14
s observed in our patient.
Pyomyositis comprises three clinical stages: invasive
insidious and nonspeciﬁc symptoms); purulent (deep abscess
ormation and inﬂammatory signs); and late stage (high
ever, severe pain, muscle ﬂuctuation and occasionally septic
hock).2,7 Purulent stage is observed in up to 90% of patients
t diagnosis,15 as evidenced herein.
Of note, the clinical presentation and the laboratory exams
f pyomyositis are nonspeciﬁc. White blood cell count can be
levated in 50–60% of cases; acute phase reactants are usually
igh15 and muscle enzymes are often normal,2 as observed
n this case. Therefore, early imaging tests are imperative for
he diagnosis of pyomyositis. X-ray studies can be used to
ule out bone lesions. Ultrasonography is an accessible, low-
ost and quick tool, but not sensitive enough, particularly
t the onset of the infection.14 Importantly, CT or magnetic
esonance imaging conﬁrms the diagnosis, and may reveal
uscle enlargement, abscess extension, joint effusions and
uid collections.15
This disease can also occur in healthy patients after local
echanical trauma,13,15 and can be associated with para-
itosis and desnutrition, also known as tropical pyomyositis.
he atypical or nonspeciﬁc presentation of pyomyositis may
elay the diagnosis and treatment in immunosuppressive
nd/or chronic diseases, such as HIV infeccion,13–15 HTLV
nfeccion,7 leukemia,13–15 diabetes,13–15 scleroderma,13 and
ermatomyositis.15 To the best of our knowledge, there
re only ﬁve cases described of pyomyositis in adult SLE
atients3–7 and only one with childhood-onset lupus who
resented pyomyositis at the age of 32.4 Therefore, the
rst case of pyomyositis in pediatric lupus population was
escribed herein.
Differential diagnosis of pyomyositis affecting the thigh
ncludes hematoma, osteomyelitis, septic arthritis, deep
enous thrombosis, cellulitis and malignant tumors.2,15
The treatment depends on the stage of disease. In the puru-
ent and late stages, intravenous broad-spectrum antibiotics
re the main therapy. Moreover, percutaneous drainage or
urgical incision may be necessary in patients refractory to
ntibiotics.2 Our patient had complete recovery after clinical
reatment.
In conclusion, we described a case of pyomyositis in C-
LE population. This report reinforces that the presence of
ocalized muscle pain in immunocompromised patients, even
ithout elevation of muscle enzymes, should raise the sus-
icion of pyomyositis. A prompt antibiotic therapy is strongly
ecommended.
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